Cargando…

The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway

PURPOSE: To explore the effects of the combination of blueberry juice and probiotics on the apoptosis of alcoholic fatty liver disease (AFLD). METHODS: Healthy C57BL/6J mice were used in the control group (CG). AFLD mice models were established with Lieber–DeCarli ethanol diet and evenly assigned to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Juanjuan, Ren, Tingting, Zhou, Mingyu, Cheng, Mingliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869661/ https://www.ncbi.nlm.nih.gov/pubmed/27274198 http://dx.doi.org/10.2147/DDDT.S102883

Ejemplares similares

Combined intake of blueberry juice and probiotics ameliorate mitochondrial dysfunction by activating SIRT1 in alcoholic fatty liver disease
por: Fan, Houmin, et al.
Publicado: (2021)

The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α
por: Ren, Tingting, et al.
Publicado: (2017)

Dietary Blueberry and Bifidobacteria Attenuate Nonalcoholic Fatty Liver Disease in Rats by Affecting SIRT1-Mediated Signaling Pathway
por: Ren, Tingting, et al.
Publicado: (2014)

Dietary Supplementation of Blueberry Juice Enhances Hepatic Expression of Metallothionein and Attenuates Liver Fibrosis in Rats
por: Wang, Yuping, et al.
Publicado: (2013)

Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1
por: Domazetovic, Vladana, et al.
Publicado: (2019)

Network Pharmacology Exploration Reveals Anti-Apoptosis as a Common Therapeutic Mechanism for Non-Alcoholic Fatty Liver Disease Treated with Blueberry Leaf Polyphenols
por: Wang, Cai-Ren, et al.
Publicado: (2021)

SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease
por: Cho, Eun-Hee
Publicado: (2014)

Evaluation of Blueberry Juice in Mouse Azoxymethane-Induced Aberrant Crypts and Oxidative Damage
por: Álvarez-González, Isela, et al.
Publicado: (2014)

Antiproliferative and Antioxidant Properties of Anthocyanin Rich Extracts from Blueberry and Blackcurrant Juice
por: Diaconeasa, Zoriţa, et al.
Publicado: (2015)

Impact of Various Factors on Color Stability of Fresh Blueberry Juice during Storage
por: Song, Hyo-Nam, et al.
Publicado: (2018)

Effects of Cryoconcentrated Blueberry Juice as Functional Ingredient for Preparation of Commercial Confectionary Hydrogels
por: Casas-Forero, Nidia, et al.
Publicado: (2022)

Athermal Concentration of Blueberry Juice by Forward Osmosis: Food Additives as Draw Solution
por: Chu, Haoqi, et al.
Publicado: (2022)

Processing of Enriched Pear Slices with Blueberry Juice: Phenolics, Antioxidant, and Color Characteristics
por: Seraglio, Siluana Katia Tischer, et al.
Publicado: (2023)

Protective effect of probiotics in patients with non-alcoholic fatty liver disease
por: Cai, Gen-shen, et al.
Publicado: (2020)

Apoptosis and non-alcoholic fatty liver diseases
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Emerging roles of SIRT1 in fatty liver diseases
por: Ding, Ren-Bo, et al.
Publicado: (2017)

Blueberry and Mulberry Juice Prevent Obesity Development in C57BL/6 Mice
por: Wu, Tao, et al.
Publicado: (2013)

Spray Drying of Blueberry Juice-Maltodextrin Mixtures: Evaluation of Processing Conditions on Content of Resveratrol
por: Leyva-Porras, César, et al.
Publicado: (2019)

Exploring the Potential of Wild Andean Blueberries for Powdered Juice Production through Spray Drying
por: Estupiñan-Amaya, Mauren, et al.
Publicado: (2023)

Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
por: Anggreini, Putri, et al.
Publicado: (2022)

Emerging Roles of SIRT1 in Alcoholic Liver Disease
por: Ren, Ruixue, et al.
Publicado: (2020)

Identification of spoilage microorganisms in blueberry juice and their inactivation by a microchip pulsed electric field system
por: Zhu, Ning, et al.
Publicado: (2018)

The Characteristics of Whey Protein and Blueberry Juice Mixed Fermentation Gels Formed by Lactic Acid Bacteria
por: Wang, Wenqiong, et al.
Publicado: (2023)

Sugar-sweetened beverages, low/no-calorie beverages, fruit juice and non-alcoholic fatty liver disease defined by fatty liver index: the SWEET project
por: Naomi, Novita D., et al.
Publicado: (2023)

Blueberry Husks and Probiotics Attenuate Colorectal Inflammation and Oncogenesis, and Liver Injuries in Rats Exposed to Cycling DSS-Treatment
por: Håkansson, Åsa, et al.
Publicado: (2012)

Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
por: Xie, Chencheng, et al.
Publicado: (2019)

Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics
por: Nagashimada, Mayumi, et al.
Publicado: (2021)

The monomer TEC of blueberry improves NASH by augmenting tRF-47-mediated autophagy/pyroptosis signaling pathway
por: Zhu, Juanjuan, et al.
Publicado: (2022)

Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat
por: Choudhury, Mahua, et al.
Publicado: (2011)

Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
por: Endo, Hitoshi, et al.
Publicado: (2013)

Recent advances in probiotication of fruit and vegetable juices
por: Rahman, Md. Saydar, et al.
Publicado: (2023)

Effect of Freeze-Thaw Cycles on Juice Properties, Volatile Compounds and Hot-Air Drying Kinetics of Blueberry
por: Zhu, Lin, et al.
Publicado: (2021)

Blueberry Juice Attenuates Pulmonary Fibrosis via Blocking the TGF-β1/Smad Signaling Pathway
por: Li, Yali, et al.
Publicado: (2022)

Silibinin Restores NAD(+) Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
por: Salomone, Federico, et al.
Publicado: (2017)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Probiotics for Alleviating Alcoholic Liver Injury
por: Gu, Zelin, et al.
Publicado: (2019)

More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease
por: Vajro, Pietro, et al.
Publicado: (2013)

Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review
por: Castillo, Valentina, et al.
Publicado: (2021)

Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
por: Sabirin, Faezah, et al.
Publicado: (2022)

Modulation of hepatic stellate cells by Mutaflor(®) probiotic in non-alcoholic fatty liver disease management
por: Hany, Noha M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ett8omrfptqgljjfutbv3ibgpk